These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24589267)

  • 1. The role of adenosine signaling in sickle cell therapeutics.
    Field JJ; Nathan DG; Linden J
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):287-99. PubMed ID: 24589267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.
    Field JJ; Lin G; Okam MM; Majerus E; Keefer J; Onyekwere O; Ross A; Campigotto F; Neuberg D; Linden J; Nathan DG
    Blood; 2013 Apr; 121(17):3329-34. PubMed ID: 23377438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting iNKT cells for the treatment of sickle cell disease.
    Field JJ; Nathan DG; Linden J
    Clin Immunol; 2011 Aug; 140(2):177-83. PubMed ID: 21429807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors.
    Lin G; Field JJ; Yu JC; Ken R; Neuberg D; Nathan DG; Linden J
    PLoS One; 2013; 8(10):e74664. PubMed ID: 24124453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine receptors and diabetes: Focus on the A(2B) adenosine receptor subtype.
    Merighi S; Borea PA; Gessi S
    Pharmacol Res; 2015 Sep; 99():229-36. PubMed ID: 26142494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine signaling in normal and sickle erythrocytes and beyond.
    Zhang Y; Xia Y
    Microbes Infect; 2012 Aug; 14(10):863-73. PubMed ID: 22634345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A
    Yu F; Zhu C; Xie Q; Wang Y
    J Med Chem; 2020 Nov; 63(21):12196-12212. PubMed ID: 32667814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts.
    Methner C; Schmidt K; Cohen MV; Downey JM; Krieg T
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1262-4. PubMed ID: 20709859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adenosine A(2A) and A(2B) receptor activation on signaling pathways and cytokine production in human uroepithelial cells.
    Säve S; Persson K
    Pharmacology; 2010; 86(3):129-37. PubMed ID: 20689344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine receptors regulate exosome production.
    Ludwig N; Azambuja JH; Rao A; Gillespie DG; Jackson EK; Whiteside TL
    Purinergic Signal; 2020 Jun; 16(2):231-240. PubMed ID: 32440820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2A receptor as a drug discovery target.
    de Lera Ruiz M; Lim YH; Zheng J
    J Med Chem; 2014 May; 57(9):3623-50. PubMed ID: 24164628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease (SCD), iNKT cells, and regadenoson infusion.
    Nathan DG; Field J; Lin G; Neuberg D; Majerus E; Onyekwere O; Keefer J; Okam M; Ross A; Linden J
    Trans Am Clin Climatol Assoc; 2012; 123():312-7; discussion 317-8. PubMed ID: 23303999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of a novel adenosine A
    Fusco I; Cherchi F; Catarzi D; Colotta V; Varano F; Pedata F; Pugliese AM; Coppi E
    Brain Res Bull; 2019 Sep; 151():174-180. PubMed ID: 31132418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine regulates the proinflammatory signaling function of thrombin in endothelial cells.
    Hassanian SM; Dinarvand P; Rezaie AR
    J Cell Physiol; 2014 Sep; 229(9):1292-300. PubMed ID: 24477600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An example of the clinical selectivity of regadenoson for the A2a adenosine receptor.
    Miyamoto MI; Clarke KA; Thomas GS; Belardinelli L
    Am Heart Hosp J; 2009; 7(2):E118-21. PubMed ID: 20354957
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretion.
    Chin A; Svejda B; Gustafsson BI; Granlund AB; Sandvik AK; Timberlake A; Sumpio B; Pfragner R; Modlin IM; Kidd M
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G397-405. PubMed ID: 22038827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation.
    Feng MG; Navar LG
    Am J Physiol Renal Physiol; 2010 Aug; 299(2):F310-5. PubMed ID: 20462966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric Interactions between Adenosine A
    Prasad K; de Vries EFJ; Elsinga PH; Dierckx RAJO; van Waarde A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel and selective fluorescent ligand for the study of adenosine A
    Patera F; Mistry SJ; Kindon ND; Comeo E; Goulding J; Kellam B; Kilpatrick LE; Franks H; Hill SJ
    Pharmacol Res Perspect; 2024 Aug; 12(4):e1223. PubMed ID: 39031734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
    Ng SK; Higashimori H; Tolman M; Yang Y
    Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.